Status:
COMPLETED
Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions:
Acute Promyelocytic Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
This study will focus on acute promyelocytic leukemia patients who have been diagnosed more than 5 years ago and their present quality of life. The possible late effects of cancer treatment can inclu...
Detailed Description
This study will focus on long-term survivors as defined by the America Cancer Society, that is surviving the initial diagnosis for more than 5 years. Previous research has investigated long-term Healt...
Eligibility Criteria
Inclusion
- APL patients previously enrolled in the studies GIMEMA AIDA0493 and AIDA2000 surviving the initial diagnosis for more than 5 years and are in CR.
- Written informed consent provided.
- Adult patients at the time of registration onto this study.
Exclusion
- Concomitant major psychiatric disorders or cognitive dysfunctions that would interfere with a self-reported evaluation.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
End Date :
July 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01910623
Start Date
February 1 2013
End Date
July 1 2014
Last Update
October 2 2014
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
Alessandria, Italy
2
Azienda Ospedaliera - Nuovo Ospedale "Torrette"
Ancona, Italy
3
Az.Ospedaliera S.G.Moscati
Avellino, Italy
4
UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
Bari, Italy